Recombinant Human FSH Treatment Outcomes in Five Boys With Severe Congenital Hypogonadotropic Hypogonadism

Näytä kaikki kuvailutiedot



Pysyväisosoite

http://hdl.handle.net/10138/292439

Lähdeviite

Kohva , E , Huopio , H , Hero , M , Miettinen , P J , Vaaralahti , K , Sidoroff , V , Toppari , J & Raivio , T 2018 , ' Recombinant Human FSH Treatment Outcomes in Five Boys With Severe Congenital Hypogonadotropic Hypogonadism ' , Journal of the Endocrine Society , vol. 2 , no. 12 , pp. 1345-1356 . https://doi.org/10.1210/js.2018-00225

Julkaisun nimi: Recombinant Human FSH Treatment Outcomes in Five Boys With Severe Congenital Hypogonadotropic Hypogonadism
Tekijä: Kohva, Ella; Huopio, Hanna; Hero, Matti; Miettinen, Päivi J.; Vaaralahti, Kirsi; Sidoroff, Virpi; Toppari, Jorma; Raivio, Taneli
Muu tekijä: University of Helsinki, Raivio Group
University of Helsinki, Raivio Group
University of Helsinki, Centre of Excellence in Stem Cell Metabolism
University of Helsinki, Raivio Group
University of Helsinki, Department of Physiology
Päiväys: 2018-10-15
Kieli: eng
Sivumäärä: 12
Kuuluu julkaisusarjaan: Journal of the Endocrine Society
ISSN: 2472-1972
URI: http://hdl.handle.net/10138/292439
Tiivistelmä: Context Recombinant human FSH (r-hFSH), given to prepubertal boys with hypogonadotropic hypogonadism (HH), may induce Sertoli cell proliferation and thereby increase sperm-producing capacity later in life. Objective To evaluate the effects of r-hFSH, human chorionic gonadotropin (hCG), and testosterone (T) in such patients. Design and Setting Retrospective review in three tertiary centers in Finland between 2006 and 2016. Patients Five boys: ANOS1 mutation in two, homozygous PROKR2 mutation in one, FGFR1 mutation in one, and homozygous GNRHR mutation in one. Prepubertal testicular volume (TV) varied between 0.3 and 2.3 mL; three boys had micropenis, three had undergone orchidopexy. Interventions Two boys received r-hFSH (6 to 7 months) followed by r-hFSH plus hCG (33 to 34 months); one received T (6 months), then r-hFSH plus T (29 months) followed by hCG (25 months); two received T (3 months) followed by r-hFSH (7 months) or r-hFSH plus T (8 months). Main Outcome Measures TV, inhibin B, anti-Müllerian hormone, T, puberty, sperm count. Results r-hFSH doubled TV (from a mean ± SD of 0.9 ± 0.9 mL to 1.9 ± 1.7 mL; P < 0.05) and increased serum inhibin B (from 15 ± 5 ng/L to 85 ± 40 ng/L; P < 0.05). hCG further increased TV (from 2.1 ± 2.3 mL to 8.6 ± 1.7 mL). Two boys with initially extremely small testis size (0.3 mL) developed sperm (maximal sperm count range, 2.8 to 13.8 million/mL), which was cryopreserved. Conclusions Spermatogenesis can be induced with gonadotropins even in boys with HH who have extremely small testes, and despite low-dose T treatment given in early puberty. Induction of puberty with gonadotropins allows preservation of fertility
Avainsanat: 3121 General medicine, internal medicine and other clinical medicine
Tekijänoikeustiedot:


Tiedostot

Latausmäärä yhteensä: Ladataan...

Tiedosto(t) Koko Formaatti Näytä
js.2018_00225.pdf 737.3KB PDF Avaa tiedosto

Viite kuuluu kokoelmiin:

Näytä kaikki kuvailutiedot